4.6 Review

MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma

Journal

CELLS
Volume 11, Issue 14, Pages -

Publisher

MDPI
DOI: 10.3390/cells11142234

Keywords

miRNA; lncRNA; adrenocortical tumor; ACC; adrenocortical adenoma; prognostic markers

Categories

Funding

  1. European Reference Network on Rare Endocrine Conditions (Endo-ERN)
  2. PRIN 2020 [2017N8CK4K]
  3. POR FESR 2014-2020
  4. RarePlatNet [CUP: B63D18000380007]

Ask authors/readers for more resources

Non-coding RNAs play a crucial role in regulating gene expression and have potential applications in the diagnosis, treatment, and management of various human diseases. Dysregulation of non-coding RNAs may be involved in the development and progression of adrenocortical carcinoma.
Non-coding RNAs (ncRNAs) are a type of genetic material that do not encode proteins but regulate the gene expression at an epigenetic level, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). The role played by ncRNAs in many physiological and pathological processes has gained attention during the last few decades, as they might be useful in the diagnosis, treatment and management of several human disorders, including endocrine and oncological diseases. Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine cancer, still characterized by high mortality and morbidity due to both endocrine and oncological complications. Despite the rarity of this disease, recently, the role of ncRNA has been quite extensively evaluated in ACC. In order to better explore the role of the ncRNA in human ACC, this review summarizes the current knowledge on ncRNA dysregulation in ACC and its potential role in the diagnosis, treatment, and management of this tumor.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available